Dr Iain Chalmers, MSc ,Douglas G Altman, DSc
Medical journals share with other elements of the clinical research community certain responsibilities to the public for the quality of medical research. Traditionally, they have tried to fulfil these responsibilities by assessing the reports submitted to them for publication and then subjecting some of these to “treatment” of various kinds before a final decision is taken about what should be published. The persisting inadequacies of these “therapeutic” efforts of journals have been made more explicit with recent improvments in the scientific quality of reviews of research.1,2 For example, there have been over 500 reports of controlled trials of a wide variety of drugs used to prevent or reduce the unpleasant movement disorders suffered by people taking antipsychotic drugs. These have been published over several decades in journals that claim to use peer review, but recent systematic reviews have shown that this vast body of research yields no information upon which practice can be based with any confidence.3 There is depressing evidence that the therapeutic efforts of journals remain inadequate; in only one of the 122 reports of randomised controlled trials of selective serotonin reuptake inhibitors were adequate details given about the method of randomisation,4 and these reporting deficiencies are present in some of the world’s most prestigious medical journals.5 Many journals are now trying to deal
0 comments:
Post a Comment